<bill session="118" type="s" number="1852" updated="2025-05-27T14:15:52Z">
  <state datetime="2023-06-15">REPORTED</state>
  <status>
    <unknown datetime="2023-06-15"/>
  </status>
  <introduced datetime="2023-06-07"/>
  <titles>
    <title type="display">Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023</title>
    <title type="short" as="reported to senate">Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023</title>
    <title type="short" as="introduced">Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023</title>
    <title type="official" as="introduced">A bill to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.</title>
  </titles>
  <sponsor bioguide_id="S001184"/>
  <cosponsors>
    <cosponsor bioguide_id="B001288" joined="2023-06-07"/>
    <cosponsor bioguide_id="W000790" joined="2023-07-26"/>
  </cosponsors>
  <actions>
    <action datetime="2023-06-07">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-06-07" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2023-06-15" state="REPORTED">
      <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.</text>
    </action>
    <action datetime="2023-09-06">
      <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.</text>
    </action>
    <calendar datetime="2023-09-06" calendar="Senate Legislative" under="General Orders" number="201">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Reported By, Markup By, Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Genetics"/>
    <term name="Health promotion and preventive care"/>
    <term name="Hereditary and development disorders"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2024-12-10T00:26:24Z" status="Reported to Senate">Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)</summary>
</bill>
